Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database
IntroductionInfliximab (IFX) was the first anti-tumor necrosis factor (TNFα) antibody to be used in the treatment of severe chronic inflammatory diseases, such as Crohn's disease and rheumatoid arthritis. A number of serious adverse drug reactions are known to be associated with IFX use; they i...
Saved in:
Main Authors: | Eve-Marie Thillard (Author), Sophie Gautier (Author), Evgeniya Babykina (Author), Louise Carton (Author), Ali Amad (Author), Guillaume Bouzillé (Author), Jean-Baptiste Beuscart (Author), Grégoire Ficheur (Author), Emmanuel Chazard (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case-crossover study to examine the change in postpartum risk of pulmonary embolism over time
by: Grégoire Ficheur, et al.
Published: (2017) -
Balancing autonomy and beneficence at the time of psychiatric discharge
by: Abhishek Jain, et al.
Published: (2018) -
Infliximab
by: İlgen Ertam Sağduyu
Published: (2022) -
Switch from Infliximab to Infliximab-dyyb for Rheumatology Indications
by: Alexi Spoto, et al.
Published: (2021) -
Infusion reaction to infliximab biosimilar after transitioning from infliximab
by: Reem Kashlan, MPH, et al.
Published: (2021)